您的位置:
首页
>
农业专利
>
详情页
DERIVES D'INDAZOLE-HETEROARYLE
专利权人:
MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG
发明人:
KLEIN, MARKUS,GERICKE, ROLF,MEDERSKI, WERNER,BEIER, NORBERT,LANG, FLORIAN
申请号:
CA2641347
公开号:
CA2641347C
申请日:
2007.01.10
申请国别(地区):
CA
年份:
2014
代理人:
摘要:
The invention relates to novel indazole derivatives as cited in claim 1, whichare inhibitors ofCHK1, CHK2 and SGK kinases and can be used to treat cancer and other diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关专利
נגזרות של אינדזול–הטרואריל ותכשירי רוקחות המכילים אותן
COMPOSITIONS AND METHODS FOR REGULATED PROTEIN EXPRESSION IN GUT
Antigen binding protein isolated fixing the heparin binding epidermal growth factor (EGF); Hg) Nucleic Acid Molecule that encodes host Cell; vector; Preparation method;On; Pharmaceutical composition that comprises; and its use to treat a disease hiperproliferativa.
SOLUBLE CD52 GLYCOPROTEINS AND ITS USE IN TREATING DISEASES REGULATED BY EFFECTOR T-CELLS
compound for treating diseases or conditions by inhibiting the activity or expression of human gh, ghr, stat5, igf-1 and / or socs and proteins regulated by human gh, ghr, stat5, socs, igf-1 and insulin; compounds for treating diseases or conditions by inhibiting the activity or expression of human gh, ghr, stat5, socs, igf-1 and insulin and human gh, ghr, stat5, socs, igf-1 and insulin regulated proteins; method for treating diseases or conditions with changes in signaling genes related to human gh, ghr, stat5 and socs; and method for treating diseases or conditions caused by growth hormone a